Skip to main content
. 2020 Nov 28;8:12–20. doi: 10.1016/j.iotech.2020.11.001

Table 4.

Clinical trials investigating immunotherapy in combination with dietary modifications

Trial no. Phase Cancer type Intervention Sponsor/investigator
NCT03192059 II Cervical/uterine Pembrolizumab + RT + immunomodulatory cocktail + dietary supplement (curcumin) University Hospital, Ghent
NCT03700437 NSCLC Carboplatin/pemetrexed + pembrolizumab, fasting-mimicking diet Indiana University

RT, radiation therapy; NSCLC, non-small cell lung cancer.